9-35608870-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006285.3(TESK1):c.1009G>A(p.Ala337Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000417 in 1,584,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006285.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000394 AC: 9AN: 228172Hom.: 0 AF XY: 0.0000327 AC XY: 4AN XY: 122394
GnomAD4 exome AF: 0.0000314 AC: 45AN: 1432444Hom.: 0 Cov.: 31 AF XY: 0.0000352 AC XY: 25AN XY: 709342
GnomAD4 genome AF: 0.000138 AC: 21AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.1009G>A (p.A337T) alteration is located in exon 10 (coding exon 10) of the TESK1 gene. This alteration results from a G to A substitution at nucleotide position 1009, causing the alanine (A) at amino acid position 337 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at